Archived documents
Documents past their public comment period for Pharmaceutical Policy.
PSG_021730 - Draft Guidance on Levalbuterol Tartrate
0 comments
Analysis in progress
Top issues in comments
PSG_008816 - Draft Guidance on Lidocaine Hydrochloride
0 comments
Analysis in progress
Top issues in comments
PSG_021850 - Draft Guidance on Magnesium Hydroxide; Omeprazole; Sodium Bicarbonate
0 comments
Analysis in progress
Top issues in comments
PSG_019962 - Draft Guidance on Metoprolol Succinate
0 comments
Analysis in progress
Top issues in comments
PSG_219373 - Draft Guidance on Metoprolol Tartrate
0 comments
Analysis in progress
Top issues in comments
PSG_017963 - Draft Guidance on Metoprolol Tartrate
0 comments
Analysis in progress
Top issues in comments
PSG_219379 - Draft Guidance on Mirdametinib
0 comments
Analysis in progress
Top issues in comments
PSG_205641 - Draft Guidance on Mometasone Furoate
0 comments
Analysis in progress
Top issues in comments
PSG_219389 - Draft Guidance on Mirdametinib
0 comments
Analysis in progress
Top issues in comments
PSG_212801 - Draft Guidance on Osilodrostat Phosphate
0 comments
Analysis in progress
Top issues in comments
PSG_216490 - Draft Guidance on Palopegteriparatide
0 comments
Analysis in progress
Top issues in comments
PSG_205739 - Draft Guidance on Patiromer Sorbitex Calcium
0 comments
Analysis in progress
Top issues in comments